Search Results - "Zugasti, Inés"

P532: KINETICS AND PROGNOSTIC VALUE OF MEASURABLE RESIDUAL DISEASE (MRD) IN PATIENTS DIAGNOSED WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH VENETOCLAX IN COMBINATION WITH HYPOMETHYLATING AGENTS by Jimenez‐Vicente, Carlos, Guijarro, Francesca, Lopez‐Guerra, Monica, Guardia‐Torrelles, Ares, Martínez Roca, Alexandra, Bataller, Alex, Esteban, Daniel, Cortés, Albert, Zugasti, Inés, Munarriz, Daniel, Colomer, Dolors, Diaz‐Beya, Marina, Esteve, Jordi

Get full text

PB1846: MANAGEMENT OF PATIENTS TREATED WITH VENETOCLAX WITH HYPOMETHYLATING AGENTS: LONG‐TERM INCIDENCE OF CYTOPENIAS AND INFECTIONS by Guardia‐Torrelles, Ares, Jimenez‐Vicente, Carlos, Roca, Alexandra Martínez, Castaño‐Díez, Sandra, Brillembourg, Helena, Guijarro, Francesca, Bataller, Àlex, Esteban, Daniel, Cortés, Albert, Zugasti, Inés, Munarriz, Daniel, Diaz‐Beya, Marina, Esteve, Jordi, Merchan, Beatriz

Get full text

Stereological estimations and neurochemical characterization of neurons expressing GABAA and GABAB receptors in the rat pedunculopontine and laterodorsal tegmental nuclei by Luquin, Esther, Paternain, Beatriz, Zugasti, Inés, Santomá, Carmen, Mengual, Elisa

“…To better understand GABAergic transmission at two targets of basal ganglia downstream projections, the pedunculopontine (PPN) and laterodorsal (LDT) tegmental…”
Get full text

Characteristics and long-term outcome in a large series of chronic myelomonocytic leukaemia patients including 104 formerly referred to as oligomonocytic by Castaño-Díez, Sandra, Pomares, Helena, Esteban, Daniel, Guijarro, Francesca, Jiménez-Vicente, Carlos, Zugasti, Inés, Álamo, José Ramón, Mayayo, Víctor Torrecillas, López-Guerra, Mònica, de la Fuente, Cristina, Charry, Paola, Cortés-Bullich, Albert, Bataller, Álex, Maluquer, Clara, Colomer, Dolors, Rozman, María, Arnan, Montserrat, Xicoy, Blanca, Esteve, Jordi, Díaz-Beyá, Marina

“…Recently modified diagnostic criteria for chronic myelomonocytic leukaemia (CMML) have lowered the cut-off for absolute monocytosis. In the largest series to…”
Get full text

Chronic myelomonocytic leukemia with NPM1 mutation or acute myeloid leukemia? by Castaño-Díez, Sandra, Álamo, José Ramón, López-Guerra, Mònica, Gómez-Hernando, Marta, Zugasti, Inés, Jiménez-Vicente, Carlos, Guijarro, Francesca, López-Oreja, Irene, Esteban, Daniel, Charry, Paola, Torrecillas, Víctor, Mont-de Torres, Lucia, Cortés-Bullich, Albert, Bataller, Álex, Guardia, Ares, Munárriz, Daniel, Carcelero, Esther, Riu, Gisela, Triguero, Ana, Tovar, Natalia, Vela, Dolors, Beà, Silvia, Costa, Dolors, Colomer, Dolors, Rozman, Maria, Esteve, Jordi, Díaz-Beyá, Marina

“…The 2022 WHO revision and the ICC classification have recently modified the diagnostic criteria for chronic myelomonocytic leukemia (CMML) and acute myeloid…”
Get full text

Substrate composition affects the development of water stress and subsequent recovery by inducing physiological changes in Cistus albidus plants by Lorente, Beatriz, Zugasti, Inés, Ortuño, María Fernanda, Nortes, Pedro, Bañón, Sebastián, Hernández, José Antonio, Sánchez-Blanco, María Jesús

“…Organic residues (compost) can be used as growth medium but may contain phytotoxic ions that, combined with a water deficit may alter the behavior of plants…”
Get full text

Serum mass spectrometry for treatment monitoring in patients with multiple myeloma receiving ARI0002h CAR T-cells by Ortiz de Landazuri, Iñaki, Oliver-Caldés, Aina, Español-Rego, Marta, Agulló, Cristina, Contreras, María Teresa, Zabaleta, Aintzane, Puig, Noemí, Cabañas, Valentín, González-Calle, Verónica, Zugasti, Inés, Inogés, Susana, Rodríguez Otero, Paula, Martin-Antonio, Beatriz, Reguera, Juan Luis, López-Diaz de Cerio, Ascensión, Aróstegui, Juan Ignacio, Uribe-Herranz, Mireia, Benítez-Ribas, Daniel, Rodríguez-Lobato, Luis Gerardo, González, Europa Azucena, Tovar, Natalia, Charry, Paola, Navarro, Sergio, Rosiñol, Laura, Tréboles, Karen, Mora, Génesis, Yagüe, Jordi, Moraleda, José María, Urbano-Ispizua, Álvaro, Mateos, María Victoria, Pascal, Mariona, Paiva, Bruno, Juan, Manel, Fernández de Larrea, Carlos

“…Chimeric antigen receptor (CAR) T-cell therapies have increased the patients with relapsed/refractory multiple myeloma (RRMM) in whom standard electrophoretic…”
Get full text

Clinical management of patients diagnosed with acute myeloid leukemia treated with venetoclax in combination with hypomethylating agents after achieving a response: a real-life study by Jiménez-Vicente, Carlos, Guardia-Torrelles, Ares, Pérez-Valencia, Amanda Isabel, Martínez-Roca, Alexandra, Castaño-Diez, Sandra, Guijarro, Francesca, Cortés-Bullich, Albert, Merchán, Beatriz, Triguero, Ana, Hernández, Isabel, Brillembourg, Helena, Munárriz, Daniel, Zugasti, Inés, Fernández-Avilés, Francesc, Diaz-Beyá, Marina, Esteve, Jordi

“…Although there is an approved indication for venetoclax and hypomethylating agents (VenHMA) and its use in different AML settings will be expanded in the…”
Get full text

Venetoclax with hypomethylating agents might lead to eradication of measurable residual disease (MRD) persisting after intensive chemotherapy in acute myeloid leukemia (AML) patients with mutated NPM1 and rearranged CBF by Jiménez-Vicente, Carlos, Martínez-Roca, Alexandra, Pomares, Helena, Castaño-Diez, Sandra, Guijarro, Francesca, López-Guerra, Mònica, Bataller, Alex, Esteban, Daniel, Cortés-Bullich, Albert, Pérez-Valencia, Amanda Isabel, Guardia-Torrelles, Ares, Zugasti, Inés, Rovira, Montserrat, Fernández-Avilés, Francesc, Colomer, Dolors, Arnan, Montserrat, Díaz-Beyá, Marina, Esteve, Jordi

Get full text

Effect of Pisolithus tinctorious on Physiological and Hormonal Traits in Cistus Plants to Water Deficit: Relationships among Water Status, Photosynthetic Activity and Plant Quality by Lorente, Beatriz, Zugasti, Inés, Sánchez-Blanco, María Jesús, Nicolás, Emilio, Ortuño, María Fernanda

“…Cistus species can form ectomycorrhizae and arbuscular mycorrhizal fungus that can bring benefits when plants are under water stress conditions. However, the…”
Get full text

AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification by Castaño-Díez, Sandra, López-Guerra, Mònica, Zugasti, Inés, Calvo, Xavier, Schulz, Felicitas Isabel, Avendaño, Alejandro, Mora, Elvira, Falantes-González, Jose Francisco, Azaceta, Gemma, Ibañez, Mariam, Chen-Liang, Tzu-Hua, Notario Mc Donnell, Cristina, Amer-Salas, Neus, Palomo, Laura, Pomares, Helena, Vila, Jordi, Bernal Del Castillo, Teresa, Jiménez-Vicente, Carlos, Esteban, Daniel, Guijarro, Francesca, Álamo Moreno, José Ramón, Cortés-Bullich, Albert, Torrecillas-Mayayo, Víctor, Triguero, Ana, Mont-de Torres, Lucía, Carcelero, Ester, Cardús, Aina, Germing, Ulrich, Betz, Beate, Rozman, Maria, Arenillas, Leonor, Zamora, Lurdes, Díez-Campelo, María, Xicoy, Blanca, Esteve, Jordi, Díaz-Beyá, Marina

“…Mutations commonly associated with acute myeloid leukemia (AML), such as CEBPA, FLT3, IDH1/2 and NPM1 are rarely found in chronic myelomonocytic leukemia…”
Get full text

Acquired hemophilia A after SARS-CoV-2 infection: A causal or casual association? by Zugasti, Inés, Guardia, Ares, Jordà-Sánchez, Raúl, Cuartas-González, Adriana, Nomdedeu, Meritxell, Arellano-Rodrigo, Eduardo

Get full text

Acquired hemophilia A after SARS-CoV-2 infection: a causal or casual association? by Zugasti, Inés, Guardia, Ares, Jordà-Sánchez, Raúl, Cuartas-González, Adriana, Nomdedeu, Meritxell, Arellano-Rodrigo, Eduardo

Get more information

Adaptation of vectors and drug-inducible systems for controlled expression of transgenes in the tumor microenvironment by Poutou, Joanna, Bunuales, Maria, Gonzalez-Aparicio, Manuela, German, Beatriz, Zugasti, Ines, Hernandez-Alcoceba, Ruben

“…Biological therapies based on recombinant proteins such as antibodies or cytokines are continuously improving the repertoire of treatments against cancer…”
Get full text

Validation of ELN 2022 Risk Classification in Patients Diagnosed with AML Undergoing Allogeneic Hematopoietic Cell Transplantation by Jimenez-Vicente, Carlos, Charry, Paola, Suarez-Lledo, Maria, Merchán Muñoz, Beatriz, Castaño-Díez, Sandra, Perez-Valencia, Amanda Isabel, Martínez-Roca, Alexandra, Guijarro, Francesca, López-Guerra, Mònica, Cortés-Bullich, Albert, Esteban, Daniel, Guardia-Torrelles, Ares, Zugasti, Ines, Munárriz, Daniel, Rosiñol, Laura, Urbano-Ispizua, Alvaro, Fernández-Avilés, Francesc, Martinez, Carmen, Díaz-Beyá, Marina, Rovira, Montserrat, Salas, Maria Queralt, Esteve, Jordi

“…Background: In 2022, the European LeukemiaNet (ELN) updated their guidelines (Döhner H et al., Blood 2022) for risk allocation of patients with acute myeloid…”
Get full text

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss by Castaño-Díez, Sandra, Zugasti, Ines, Calvo, Xavier, Schulz, Felicitas, Avendaño Pita, Alejandro, Mora, Elvira, Falantes, Jose Francisco, Azaceta, Gemma, Ibáñez, Mariam, Chen, Tzu, Notario, Cristina, Amer Salas, Neus, López-Guerra, Mònica, Jimenez-Vicente, Carlos, Esteban, Daniel, Guijarro, Francesca, Álamo Moreno, José Ramón, Cortés-Bullich, Albert, Munárriz, Daniel, Torrecillas-Mayayo, Víctor, Triguero, Ana, Tovar, Natalia, Martínez-Roca, Alexandra, Merchán Muñoz, Beatriz, Carcelero, Esther, Germing, Ulrich, Betz, Beate, Rozman, María, Arenillas, Leonor, Zamora, Lurdes, Diez-Campelo, Maria, Xicoy, Blanca, Esteve, Jordi, Díaz-Beyá, Marina

“…CMML is rarely associated with AML typical mutations such as NPM1, FLT3, CEBPA and IDH1/2 (mutAML-CMML). It is unknown what its clinical meaning is and if its…”
Get full text

Venetoclax and Azacytidine Treatment for High Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia As a Bridge Therapy to Transplant. a GESMD Study by Zugasti, Ines, Castaño-Díez, Sandra, Esteban, Daniel, Avendaño Pita, Alejandro, Pomares, Helena, Pérez González, Ana, Garcia-Avila, Sara, Padilla-Conejo, Irene, de la Fuente, Cristina, Martínez-Roca, Alexandra, Guijarro, Francesca, Álamo Moreno, José Ramón, Jimenez-Vicente, Carlos, Cortés-Bullich, Albert, Torrecillas, Victor, Guardia, Ares, Munárriz, Daniel, Carcelero, Esther, Suarez-Lledo, Maria, Salas, Maria Queralt, Lopez, Felix, Ramos, Fernando, Xicoy, Blanca, Valcarcel, David, Arnan Sangerman, Montserrat, Diez-Campelo, Maria, Martinez, Carmen, Rovira, Montserrat, Fernández-Avilés, Francesc, Esteve, Jordi, Díaz-Beyá, Marina

“…Introduction Allogeneic hematopoietic cell transplantation (alloHCT) is the only potentially curative treatment for myelodysplastic syndromes (MDS) and chronic…”
Get full text